loading
前日終値:
$8.19
開ける:
$8.35
24時間の取引高:
12,339
Relative Volume:
0.09
時価総額:
$48.17M
収益:
-
当期純損益:
$-17.06M
株価収益率:
-0.1161
EPS:
-70.7173
ネットキャッシュフロー:
$-14.18M
1週間 パフォーマンス:
-6.92%
1か月 パフォーマンス:
-22.17%
6か月 パフォーマンス:
-86.37%
1年 パフォーマンス:
-98.68%
1日の値動き範囲:
Value
$7.99
$8.97
1週間の範囲:
Value
$7.72
$9.45
52週間の値動き範囲:
Value
$7.72
$552.00

Cns Pharmaceuticals Inc Stock (CNSP) Company Profile

Name
名前
Cns Pharmaceuticals Inc
Name
セクター
Healthcare (1164)
Name
電話
1-800-946-9185
Name
住所
2100 WEST LOOP SOUTH, HOUSTON
Name
職員
4
Name
Twitter
Name
次回の収益日
2024-11-13
Name
最新のSEC提出書
Name
CNSP's Discussions on Twitter

CNSP を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
CNSP
Cns Pharmaceuticals Inc
7.99 48.17M 0 -17.06M -14.18M -70.72
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
467.13 120.60B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
555.21 60.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
327.26 42.87B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
595.98 36.23B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
307.01 31.54B 3.81B -644.79M -669.77M -6.24

Cns Pharmaceuticals Inc Stock (CNSP) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2020-12-28 ダウングレード Ladenburg Thalmann Buy → Neutral
2020-08-24 開始されました Ladenburg Thalmann Buy

Cns Pharmaceuticals Inc (CNSP) 最新ニュース

pulisher
Jul 28, 2025

CNS Pharmaceuticals Inc. Company’s Quarterly Earnings Growth: What the Numbers SaySwing Setup With Technical Confirmation Explained - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Published on: 2025-07-28 14:09:47 - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Will CNS Pharmaceuticals Inc. outperform the market Free Buy Low Sell High Stock Watch - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Is it the right time to buy CNS Pharmaceuticals Inc. stockHigh-yield investments - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What makes CNS Pharmaceuticals Inc. stock price move sharply 2-Day Signal Watch with Forecast Outcome - metal.it

Jul 28, 2025
pulisher
Jul 27, 2025

Why is CNS Pharmaceuticals Inc. stock attracting strong analyst attentionCapitalize on trading strategies that deliver - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How strong is CNS Pharmaceuticals Inc. company’s balance sheetExplosive earnings growth - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Does CNS Pharmaceuticals Inc. stock perform well during market downturnsUnprecedented market success - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Published on: 2025-07-27 20:34:14 - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 26, 2025

What makes CNS Pharmaceuticals Inc. stock price move sharplyFree Stock Market Courses - metal.it

Jul 26, 2025
pulisher
Jul 25, 2025

CNS Pharmaceuticals Inc. Stock Analysis and ForecastFree Market Dynamics Reports - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What drives CNS Pharmaceuticals Inc. stock priceFree Stock Movement Tracking - Autocar Professional

Jul 25, 2025
pulisher
Jul 23, 2025

What analysts say about CNS Pharmaceuticals Inc. stockFree Consultation - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Is CNS Pharmaceuticals Inc. a good long term investmentSkyrocketing returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Why CNS Pharmaceuticals Inc. stock attracts strong analyst attentionPrecision Entry Strategy - beatles.ru

Jul 22, 2025
pulisher
Jul 22, 2025

CNS Pharmaceuticals Announces Reverse Stock Split - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

CNS Pharmaceuticals to Participate in the Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference - 富途牛牛

Jul 22, 2025
pulisher
Jul 22, 2025

CNS Pharmaceuticals (NASDAQ: CNSP) CEO Featured In Virtual Investor Summer Spotlight Conference - Barchart.com

Jul 22, 2025
pulisher
Jul 22, 2025

CNS Pharmaceuticals to Participate in the Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference - Yahoo Finance

Jul 22, 2025
pulisher
Jul 22, 2025

CNS Pharmaceuticals CEO Shares Vision at Virtual Investor Conference - citybuzz -

Jul 22, 2025
pulisher
Jul 20, 2025

CNS Pharmaceuticals To Carry Out 1-for-12 Reverse Stock Split On July 22nd, 2025 - 富途牛牛

Jul 20, 2025
pulisher
Jul 20, 2025

CNS Pharmaceuticals Implements 1-for-12 Reverse Stock Split to Consolidate Shares and Improve Market Position - AInvest

Jul 20, 2025
pulisher
Jul 19, 2025

Published on: 2025-07-19 01:04:34 - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

CNS Pharmaceuticals (NASDAQ: CNSP) Announces 1-for-12 Reverse Stock Split Effective July 22 - Barchart.com

Jul 18, 2025
pulisher
Jul 18, 2025

CNS Pharmaceuticals announces 1-for-12 reverse stock split By Investing.com - Investing.com Nigeria

Jul 18, 2025
pulisher
Jul 18, 2025

CNS Pharmaceuticals announces 1-for-12 reverse stock split - Investing.com

Jul 18, 2025
pulisher
Jul 18, 2025

Brain Cancer Drug Developer CNS Pharmaceuticals Announces 1:12 Reverse Split to Maintain Nasdaq Listing - Stock Titan

Jul 18, 2025
pulisher
Jul 15, 2025

How CNS Pharmaceuticals Inc. stock performs during market volatility3x Growth Potential - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

CNS Pharmaceuticals Posts Investor Presentation on Brain Cancer - TipRanks

Jul 15, 2025
pulisher
Jul 15, 2025

CNSP SEC FilingsCNS Pharmaceuticals 10-K, 10-Q, 8-K Forms - Stock Titan

Jul 15, 2025

Cns Pharmaceuticals Inc (CNSP) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$76.97
price up icon 9.66%
$37.41
price up icon 0.93%
$103.60
price up icon 1.81%
$27.00
price down icon 1.60%
$110.37
price down icon 2.17%
biotechnology ONC
$307.08
price up icon 4.40%
大文字化:     |  ボリューム (24 時間):